Gabapentin and Beovu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Beovu (brolucizumab-dbll). Common drug interactions include iridocyclitis among females and retinal vasculitis among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Beovu. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Beovu?

Beovu has active ingredients of brolucizumab-dbll. eHealthMe is studying from 3,872 Beovu users. Check the latest studies of Beovu.

On Jul, 12, 2026

13 people who take Gabapentin and Beovu together, and have interactions are studied.

What are the common drug interactions of Gabapentin and Beovu, by gender? *:

female:

Iridocyclitis (inflammation of the iris and ciliary body of the eye)
Visual acuity reduced (reduced clearness of vision)
Eye pain
Blindness
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Corneal degeneration (abnormal deposition of substances in the transparent front part of the eye)
Corneal disorder
Corneal opacity (scarring or clouding of the cornea)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Eye inflammation

male:

Retinal vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels)
Vitreous floaters (spots before the eyes)
Metamorphopsia (a type of distorted vision in which a grid of straight lines appears wavy and parts of the grid may appear blank)
Pneumonia
Visual impairment
Uveitis (inflammation of the uvea)
Vision blurred
Visual acuity reduced (reduced clearness of vision)
Vitreous opacities (vitreous opacities generally develop as aging changes within the eye)
Amyloidosis (a tumour within which amyloid is produced)

What are the common drug interactions of Gabapentin and Beovu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

60+:

Visual acuity reduced (reduced clearness of vision)
Iridocyclitis (inflammation of the iris and ciliary body of the eye)
Uveitis (inflammation of the uvea)
Anterior chamber inflammation
Ocular discomfort (a generic expression when there is lack of ease in/about the eyes)
Retinal vasculitis (a sight-threatening inflammatory eye condition that involves the retinal vessels)
Vision blurred
Ocular hypertension (intraocular pressure higher than normal)
Retinal haemorrhage (bleeding from retina)
Retinal vascular occlusion (a blockage of the small veins that carry blood away from the retina)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 38.46%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 5 people, 38.46%
Joint Pain: 3 people, 23.08%
Arrhythmias (irregular heartbeat): 3 people, 23.08%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 23.08%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 3 people, 23.08%
Insomnia (sleeplessness): 3 people, 23.08%
Vitritis (inflammation of the vitreous humour of the eye): 3 people, 23.08%
Type 2 Diabetes: 3 people, 23.08%
Neuropathy Peripheral (surface nerve damage): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Beovu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously